Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Marksans Pharma Limited

Marksans Pharma is a pharmaceutical company involved in the formulation, manufacturing, and marketing of finished dosage pharmaceutical formulations, with a global footprint.

COM:MARKSANSPHARMA

Marksans Pharma

Last Close

288.60

12/11 09:59

Market Cap

87.17B

Beta: -

Volume Today

6.81M

Avg: -

Financials Not Available